Prenatal Cell-free DNA Screening

Practice determining which patients are likely to benefit from cell-free DNA screening, or noninvasive prenatal testing, and how to interpret results. 


Prenatal Cell-free DNA Screening

Prenatal providers and patients have more options than ever before for testing and screening for fetal aneuploidy, including cell-free DNA screening, also called noninvasive prenatal testing (NIPS or NIPT). While cell-free DNA screening is a powerful tool, it is not the best test for all pregnant women. The technology behind cell-free DNA screening enables high detection rates for Down syndrome and other chromosome conditions, but also confers specific benefits, limitations, and challenges in results interpretation and counseling.  Learn about this technology using the five parts of this module: overview information via an animated video; practice cases to facilitate learning-by-doing; "dig deeper" for more in-depth topics; and logistics and additional resources for more detail.

    ACCESS CME MODULE         ACCESS CNE MODULE    

 

 

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Medical Association designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing nursing education activity was approved by the Northeast Multi-State Division (NE-MSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.


CME and CNE modules on the clinical applications of genetic testing

How can genetics be used in clinic with my patients? Can genetic information really improve outcomes? Genetic testing is constantly changing. How can I keep up?

Precision Medicine for Your Practice is an educational program being developed by Scripps Research Translational Institute (Scripps), the American Medical Association (AMA), and The Jackson Laboratory (JAX) to help clinicians answer these questions. In each module, you will have the opportunity to:

  • Practice applying genetic information to realistic cases
  • Assess the utility of genetic information
  • Learn about benefits and limitations of new genetic tests

This on-demand, interactive program will consist of a series of 12 modules that are 15-30 minutes, case-based and aim to build clinical skills and impact patient care. Topics include prenatal testing, targeted therapy in oncology, genomic sequencing, cardiogenomics, neurogenomics, pharmacogenomics and ethics in precision medicine. Modules will be released individually, and each will be designated for continuing medical education (CME) and continuing nursing education (CE) credit.